SeQuent Scientific shines on getting ‘Certificate of Suitability’ approval for Diclazuril API

29 Jan 2021 Evaluate

Sequent Scientific is currently trading at Rs. 215.15, up by 3.60 points or 1.70% from its previous closing of Rs. 211.55 on the BSE.

The scrip opened at Rs. 216.00 and has touched a high and low of Rs. 218.05 and Rs. 214.55 respectively. So far 250 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 230.00 on 22-Jan-2021 and a 52 week low of Rs. 52.00 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 222.80 and Rs. 206.15 respectively. The current market cap of the company is Rs. 5254.29 crore.

The promoters holding in the company stood at 53.86%, while Institutions and Non-Institutions held 14.84% and 31.30% respectively.

SeQuent Scientific (SeQuent) has received ‘Certificate of Suitability’ (CEP) for its generic active pharmaceutical ingredient (API) Diclazuril in the EU. Diclazuril is an antiprotozoal drug and is a preferred drug of choice for treating coccidiosis in livestock due to zero-day withdrawal period. It is also used in horses to treat equine protozoal myeloencephalitis caused by Sarcocystis neurona.

Sequent/Alivira is the second company in the world to receive approval for Diclazuril from the European Directorate for the Quality of Medicines (EDQM).The product was also recently commercialized in the US with supplies to the innovator. Diclazuril is manufactured at Alivira's Vizag facility, the only USFDA approved veterinary API site in India.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×